The antitumor activity of the novel compound Jesridonin on human esophageal carcinoma cells

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Wang, Cong ^a   Jiang, Liping ^a   Wang, Saiqi ^a   Shi, Hongge ^a   Wang, Junwei ^a   Wang, Ran ^a   Li, Yongmei ^a   Dou, Yinhui ^a   Liu, Ying ^a   Hou, Guiqin ^a   Ke, Yu ^a   Liu, Hongmin ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CASPASE 3; CASPASE 8; CASPASE 9; DEATH RECEPTOR; FLUORESCEIN ISOTHIOCYANATE; FLUOROURACIL; GAMMA GLUTAMYLTRANSFERASE; JESRIDONIN; LIPOCORTIN 5; MITOCHONDRIAL PROTEIN; ORIDONIN; PLANT MEDICINAL PRODUCT; PROTEIN BCL 2; PROTEIN MDM2; PROTEIN P53; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; KAURANE DERIVATIVE; TUMOR PROTEIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD ANALYSIS; CANCER CHEMOTHERAPY; CANCER INHIBITION; CARCINOMA CELL LINE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG DOSE COMPARISON; DRUG STRUCTURE; ENZYME ACTIVATION; ESOPHAGUS CARCINOMA; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MITOSIS INHIBITION; MOUSE; MTT ASSAY; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TUNEL ASSAY; ANIMAL; DRUG SCREENING; ESOPHAGUS TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

MUS MUSCULUS;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DITERPENES, KAURANE; ESOPHAGEAL NEOPLASMS; HUMANS; MICE; NEOPLASM PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84939129698     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0130284     Document Type: Article

References (35)

1. Liu CJ, Zhao ZH. Research progress of Rabdosia rubescens. China Pharmaceutical Journal(Chinese). 1998; 33: 577-581.
2. Xu ZK. Rabdosia rubescens is expected to become the second paclitaxel. Modern traditional Chinese Medicine(Chinese). 2007; 9: 43-45.
3. Wang RL. Rabdosia rubescens treatment of hepatocellular carcinoma:clinical observation of 31 cases. Cancer(Chinese). 1984; 1: 50.
4. Wang RL, Wang LX. Clinical results of 95 cases esophageal carcinoma patients treated by Rabdosia rubescens. Study of tumor prevention and treatment(Chinese). 1994; 11: 86-87.
5. Fan Q, Yuan H, Huang SW. Development of new dosage form of Rabdosia rubescens anticancer. Journal of medical research(Chinese). 2010; 39: 14-16.
6. Zuo HJ, Li D, Wu B, Gao HY, Wu LJ, Chi DQ. Chemical constituents of Rabdosia rubescens and its antitumor activity. Journal of Shenyang Pharmaceutical University(Chinese). 2005; 22: 258-261.
7. Sun HD, Huang SX, Han QB. Diterpenoids from Isodon species and their biological activities. Natural Product Reports. 2006; 23: 673. PMID: 17003905
8. Liu J, Liang JY, Xie T. Research progress of Rabdosia rubescens. Strait Pharmaceutical Journal(Chinese). 2004; 16: 1-7.
9. Liu Z, Ouyang L, Peng H, Zhang WZ. Oridonin: targeting programmed cell death pathways as an antitumour agent. Cell Proliferation. 2012; 45: 499-507. doi: 10.1111/j.1365-2184.2012.00849.x PMID: 23106297
10. Li CY, Wang EQ, Cheng Y, Bao JK. Oridonin: An active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics. The International Journal of Biochemistry & Cell Biology. 2011; 43: 701-704.
11. Zang LH, Xu Q, Ye YC, Li X, Liu YQ, Tanshiro S, et al. Autophagy enhanced phagocytosis of apoptotic cells by oridonin-treated human histocytic lymphoma U937 cells. Archives of Biochemistry and Biophysics. 2012; 518: 31-41. doi: 10.1016/j.abb.2011.11.019 PMID: 22155150
12. Ren KK, Wang HZ, Xie LP, Chen DW, Liu X, Sun J, et al. The effects of oridonin on cell growth, cell cycle, cell migration and differentiation in melanoma cells. Journal of Ethnopharmacology. 2006; 103: 176-180. PMID: 16169170
13. Lou HY, Gao L, Wei XB, Zhang Z, Zheng DD, Zhang DR, et al. Oridonin nanosuspension enhances anti-tumor efficacy in SMMC-7721 cells and H22 tumor bearing mice. Colloids and Surfaces B: Biointerfaces. 2011; 87: 319-325. doi: 10.1016/j.colsurfb.2011.05.037 PMID: 21676599
14. Leung CH, Grill SP, Lam W, Han QB, Sun HD, Cheng YC. Novel mechanism of inhibition of NF-κB DNA-binding activity by diterpenoids isolated from Isodon Rubescens. Molecular Pharmacology. 2005; 68: 286-297. PMID: 15872117
15. Hsieh TC, Wijeratne EK, Liang JY, Gunatilaka AL, Wu JM. Differential control of growth, cell cycle progression, and expression of NF-κB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens. Biochemical and Biophysical Research Communications. 2005; 337: 224-231. PMID: 16176802
16. Tian W, Chen SY. Recent advances in the molecular basis of anti-neoplastic mechanisms of oridonin. Chinese Journal of Integrative Medicine. 2013; 19: 315-320. doi: 10.1007/s11655-013-1437-3 PMID: 23546635
17. Zhou GB, Chen SJ, Wang ZY, Chen Z. Back to the future of oridonin: again, compound from medicinal herb shows potent antileukemia efficacies in vitro and in vivo. Cell Research. 2007; 17: 274-276. PMID: 17426700
18. Eliaš J, Dimitrio L, Clairambault J, Natalini R. The p53 protein and its molecular network: Modelling a missing link between DNA damage and cell fate. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 2014; 1844: 232-247.
19. Creagh EM, Conroy H, Martin SJ. Caspase-activation pathways in apoptosis and immunity. Immunological reviews. 2003; 193: 10-21. PMID: 12752666
20. Woo GH, Bak EJ, Nakayama H, Doi K. Molecular mechanisms of hydroxyurea(HU)-induced apoptosis in the mouse fetal brain. Neurotoxicology and Teratology. 2006; 28: 125-134. PMID: 16356682
21. Giansanti V, Tillhon M, Mazzini G, Prosperi E, Lombardi P, Scovassi AI. Killing of tumor cells: A drama in two acts. Biochemical Pharmacology. 2011; 82: 1304-1310. doi: 10.1016/j.bcp.2011.05.023 PMID: 21645496
22. Mohan S, Abdul AB, Abdelwahab SI, Al-Zubairi AS, Sukari MA, Abdullah R, et al. Typhonium flagelliforme induces apoptosis in CEMss cells via activation of caspase-9, PARP cleavage and cytochrome c release: Its activation coupled with G0/G1 phase cell cycle arrest. Journal of Ethnopharmacology. 2010; 131: 592-600. doi: 10.1016/j.jep.2010.07.043 PMID: 20673794
23. Turner N, Moretti E, Siclari O, Migliaccio I, Santarpia L, D'Incalci M, et al. Targeting triple negative breast cancer: Is p53 the answer? Cancer Treatment Reviews. 2013; 39: 541-550. doi: 10.1016/j.ctrv.2012.12.001 PMID: 23321033
24. Komarova EA, Gudkov AV. Suppression of p53: a New Approach to Overcome Side Effects of Antitumor Therapy. Biochemistry. 2000; 65: 41-48. PMID: 10702639
25. Sax JK, El-Deiry WS. p53 downstream targets and chemosensitivity. Cell Death Differ. 2003; 10: 413-417. PMID: 12719718
26. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nature Reviews Cancer. 1999; 2: 594-604.
27. Zhang YH, Wu YL, Tashiro S, Onodera S, Ikejima T. Reactive oxygen species contribute to oridonin-induced apoptosis and autophagy in human cervical carcinoma HeLa cells. Acta Pharmacologica Sinica. 2011; 32: 1266-1275. doi: 10.1038/aps.2011.92 PMID: 21892202
28. Khan N, Adhami VM, Mukhtar H. Apoptosis by dietary agents for prevention and treatment of cancer. Biochemical Pharmacology. 2008; 76: 1333-1339. doi: 10.1016/j.bcp.2008.07.015 PMID: 18692026
29. Nakano K, Vousden K. PUMA, a Novel Proapoptotic Gene, Is Induced by p53. Molecular Cell. 2001; 7: 683-694. PMID: 11463392
30. Elizabeth A. Slee CASJ. Demolition Phase of Apoptosis Distinct, Non-redundant Roles during the Executioner Caspase-3, -6, and -7 Perform and degradation. The Journal of Biological Chemistry. 2001; 276: 7320-7326. PMID: 11058599
31. Huang LJ, Zhang T, Li S, Duan JT, Ye F, Li HX, et al. Anthraquinone G503 Induces Apoptosis in Gastric Cancer Cells through the Mitochondrial Pathway. PLoS ONE. 2014; 9: e108286. doi: 10.1371/journal.pone.0108286 PMID: 25268882
32. Marzo I, Naval J. Bcl-2 family members as molecular targets in cancer therapy. Biochemical Pharmacology. 2008; 76: 939-946. doi: 10.1016/j.bcp.2008.06.009 PMID: 18638457
33. Brunelle JK, Letai A. Control of mitochondrial apoptosis by the Bcl-2 family. Journal of Cell Science. 2009; 122: 437-441. doi: 10.1242/jcs.031682 PMID: 19193868
34. Christina M, Angelika H, Bernd P, Martina P. Simultaneous detection of a cell surface antigen and apoptosis by microwave-sensitized TUNEL assay on paraffin sections. Journal of Immunological Methods. 2006; 316: 163-166. PMID: 17034813
35. Li XS, Xu X, Ji T, Liu ZB, Gu M, Hoang BH, et al. Dietary feeding of flavokawain A, a Kava chalcone, exhibits a satisfactory safety profile and its association with enhancement of phase II enzymes in mice. Toxicology Reports. 2014; 1: 2-11. PMID: 25379458